http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-95505-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69b61dda31f1fd520ae4f9192cfac897
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-08
filingDate 1986-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168f1a87ae668604efda31e123044a66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_847870ecae80fba1f4ccc28274177fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e5581fb50ed46d457231631d6adcd83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2355b58cefd87e207441e6b69acb0b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5987ed505149f4804169d79f284d3e
publicationDate 1988-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RO-95505-B1
titleOfInvention PROCEDURE FOR OBTAINING A PRAZOLIDINE DERIVATIVE
abstract The invention relates to a process for the preparation of a pyrazolidine derivative used as a medicine consisting of the molecular combination of clofexamide with phenylbutazone by the initial amidation reaction between 4-chlorophenoxyacetic acid and N, N-diethylaminoethylamine followed by reaction between the resulting acetamide derivative and phenylbutazone , according to the main invention with specification n ° 91023. The process consists in contacting phenylbutazone in the presence of polar solvents selected from acetone, isopropyl alcohol, ethyl alcohol in a ratio of 1: 1 in order to increase the whiteness of the finished product, in the toluene (or xylene) solution of clofenoxide 1: 5 and 1: 6 (by volume) to toluene (or xylene) at 10 ... 25 ° C, the product isolated by filtration at 0-10 ° C is recrystallized from lower alcohols such as, for example, ethyl alcohol.
priorityDate 1986-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415872023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID194699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411272340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57254831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26229

Total number of triples: 34.